Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance
Go back to Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 28.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.76 | 52 Week High | $117.12 | |||
| Open | $28.76 | 52 Week Low | $46.52 | |||
| Day High | $28.76 | P/E | N/A | |||
| Day Low | $28.76 | EPS | $-1.97 | |||
| Volume | 21 | |||||
